Search

Search Constraints

You searched for: Author/Creator Vosoughi, Reza

Search Results

3. Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis. (15th July 2021)

4. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. Issue 7 (July 2022)

8. Safety and efficacy of venoplasty in MS: A randomized, double-blind, sham-controlled phase II trial. (30th October 2018)